About CCR Ostrava, s.r.o.
Clinical Trials at CCR Ostrava, s.r.o.
During the past decade, CCR Ostrava, s.r.o. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CCR Ostrava, s.r.o." #1 sponsor was "Pfizer" with 3 trials, followed by "Incyte Corporation" with 2 trials
sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Fresenius Kabi SwissBioSim GmbH"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CCR Ostrava, s.r.o."
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at CCR Ostrava, s.r.o.
According to Clinical.Site data, the most researched conditions in "CCR Ostrava, s.r.o." are
"Dermatitis, Atopic" (2 trials), "Active Psoriatic Arthritis" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atopic Dermatitis" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "CCR Ostrava, s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at CCR Ostrava, s.r.o.
Most popular intervention types in "CCR Ostrava, s.r.o." are "Drug" (12 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ruxolitinib cream" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CCR Ostrava, s.r.o.
The vast majority of trials in "CCR Ostrava, s.r.o." are
11 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CCR Ostrava, s.r.o.
Currently, there are NaN active trials in "CCR Ostrava, s.r.o.".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in CCR Ostrava, s.r.o.,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in CCR Ostrava, s.r.o., 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".